2011
DOI: 10.1016/j.fitote.2011.08.016
|View full text |Cite
|
Sign up to set email alerts
|

Chip-based drug screening for inhibiting α-glucosidase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Up to now, SPR has been used as a new analytical device to fish out binders of drug targets from pure synthetic or natural molecules and natural product extracts for drug screening, such as protein tyrosine phosphatase 1b (PTP1B) binders [23], ␣-glucosidase binders [24], DNA binders [18], etc. Most ligands bind to HSA in a reversible manner by means of weak chemical bonds such as ionic, van der Waals, hydrogen and hydrophobic bonds with the hydroxyl, carboxyl or other reversible sites available in the amino acids of HSA [25].…”
Section: Optimization Of Spr Screeningmentioning
confidence: 99%
“…Up to now, SPR has been used as a new analytical device to fish out binders of drug targets from pure synthetic or natural molecules and natural product extracts for drug screening, such as protein tyrosine phosphatase 1b (PTP1B) binders [23], ␣-glucosidase binders [24], DNA binders [18], etc. Most ligands bind to HSA in a reversible manner by means of weak chemical bonds such as ionic, van der Waals, hydrogen and hydrophobic bonds with the hydroxyl, carboxyl or other reversible sites available in the amino acids of HSA [25].…”
Section: Optimization Of Spr Screeningmentioning
confidence: 99%